BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Triple therapy
1
Breaking barriers in the first-line Helicobacter pylori treatment: Chinese multicenter trial validates vonoprazan-based triple therapy
10/27/2025 8:08:15 AM | Browse: 206 | Download: 345
2
Declining eradication rates of helicobacter pylori with standard triple therapy in Addis Ababa, Ethiopia
1/20/2025 7:38:54 AM | Browse: 222 | Download: 896
3
From biomarker discovery to combined therapies: Advancing hepatocellular carcinoma treatment strategies
10/25/2024 10:27:35 AM | Browse: 161 | Download: 586
4
Role of high dose amoxicillin dual therapy for Helicobacter pylori eradication in an Irish cohort: A prospective study
10/24/2024 9:16:58 AM | Browse: 219 | Download: 769
5
Helicobacter pylori: High dose amoxicillin does not improve primary or secondary eradication rates in an Irish cohort
5/29/2024 12:34:21 PM | Browse: 89 | Download: 227
6
Etiopathogenic theories about long COVID
6/21/2023 9:17:20 AM | Browse: 344 | Download: 1083
7
Two-day enema antibiotic therapy for parasite eradication and resolution of symptoms
7/14/2020 3:42:19 PM | Browse: 1218 | Download: 2517
8
Role of concomitant therapy for Helicobacter pylori eradication: A technical note
10/12/2016 2:18:00 PM | Browse: 1391 | Download: 2243
9
Hybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis
12/6/2015 1:18:00 PM | Browse: 1144 | Download: 2490
10
Pharmacological therapy used in the elimination of Helicobacter pylori infection: A Review
1/7/2015 11:06:00 AM | Browse: 1230 | Download: 1965
11
IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients
10/1/2014 8:25:00 PM | Browse: 1103 | Download: 1273
12
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication
9/12/2014 8:41:00 PM | Browse: 1215 | Download: 1128
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.